Most Popular
-
1
Blackpink's solo journeys: Complementary paths, not competition
-
2
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
3
Smugglers caught disguising 230 tons of Chinese black beans as diesel exhaust fluid
-
4
[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
-
5
Dongduk Women’s University halts coeducation talks
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
-
6
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
7
OpenAI in talks with Samsung to power AI features, report says
-
8
Two jailed for forcing disabled teens into prostitution
-
9
Disney+ offers sneak peek at 2025 lineup of Korean originals
-
10
South Korean military plans to launch new division for future warfare
Celltrion, a local bio company, on Monday had its biosimilar for an antibody against arthritis approved.
This is the first time an antibody copy treatment was approved in the world, the company said.
The Korea Food and Drug Administration on Monday authorized “Remsima,” a biosimilar of Janssen’s “Remicade.” The company has conducted clinical trials on a total of 856 patients from 29 countries.
The drug maker said Remsima could replace Remicade for use for rheumatic arthritis, ankylosing spondylitis, psoriasis and other conditions.
This is the first time an antibody copy treatment was approved in the world, the company said.
The Korea Food and Drug Administration on Monday authorized “Remsima,” a biosimilar of Janssen’s “Remicade.” The company has conducted clinical trials on a total of 856 patients from 29 countries.
The drug maker said Remsima could replace Remicade for use for rheumatic arthritis, ankylosing spondylitis, psoriasis and other conditions.
-
Articles by Korea Herald
